Biologic Drugs

May 29, 2018
By Pharmaceutical Technology Editors
The European Commission has approved Zessly (infliximab), a biosimilar to Johnson & Johnson’s blockbuster Remicade (infliximab).
May 25, 2018
By Pharmaceutical Technology Editors
The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.
May 24, 2018
By Pharmaceutical Technology Editors
In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.
May 23, 2018
By Pharmaceutical Technology Editors
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 16, 2018
By Pharmaceutical Technology Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 16, 2018
By Pharmaceutical Technology Editors
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
May 15, 2018
Pharmaceutical Technology
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
May 15, 2018
Pharmaceutical Technology
Understanding the advantages and suitability of different methods to measure residual moisture content in lyophilized materials--and the respective limitations--aids in selecting the most appropriate method for testing.
May 02, 2018
Pharmaceutical Technology
Bioprocess understanding, the right equipment, and automation help, but multifunctional teamwork is the key to API production success.
May 02, 2018
Pharmaceutical Technology
A skilled workforce is needed to deliver on technology’s promising medical advances.
native1_300x100
lorem ipsum